- Home
- / AnaptysBio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
AnaptysBio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$30.8
2024-10-29
Market Capitalization
$930.2 M
2024-10-29
Revenue
$234.6 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.0M | 5.0M | 8.0M | 75.0M | 63.2M | 10.3M | 17.2M | 91.3M | 234.6M |
| General and administrative expense | 9.3M | 15.5M | 16.1M | 18.9M | 21.5M | 36.6M | 41.9M | 42.4M | |
| Operating expense total | 38.8M | 71.7M | 115.4M | 98.9M | 125.4M | 206.2M | |||
| EBIT | (28.8M) | (66.7M) | (107.4M) | (23.9M) | (56.8M) | (115.2M) | (164.4M) | (114.9M) | |
| EBIT margin, % | -287.8% | -1334.4% | -1342.9% | -31.8% | -1119.4% | -125.9% | |||
| Interest income | 1.6M | 6.7M | 11.0M | 4.0M | 431.0K | 7.6M | 18.9M | 19.8M | |
| Interest expense | 42.1M | ||||||||
| Pre tax profit | (30.1M) | (61.8M) | (97.5M) | (19.9M) | (57.8M) | (128.7M) | (163.6M) | (145.2M) | (13.1M) |
| Income tax expense | (192.0K) | (152.0K) | 24.0K | (4.0K) | 3.0K | 164.0K | |||
| Net Income | (30.1M) | (61.7M) | (97.3M) | (19.9M) | (57.8M) | (128.7M) | (163.6M) | (145.2M) | |
| EPS | (4.6) | (6.0) | (5.1) | (0.5) |